We are live on ! Find out more
Two Sigma Advisers

Two Sigma Advisers Portfolio holdings

AUM $51.4B
1-Year Est. Return 31.07%
This Fund
S&P 500
This Quarter Est. Return
-3%
1 Year Est. Return
+31.07%
3 Year Est. Return
+128.94%
5 Year Est. Return
+161.75%
10 Year Est. Return
+607.04%
AUM
$44.4B
AUM Growth
+$1.2B
Cap. Flow
+$3.32B
Cap. Flow %
7.48%
Top 10 Hldgs %
17.65%
Holding
2,641
New
312
Increased
1,037
Reduced
994
Closed
281

Top Sells

Rank Stock Value
1
V icon
Visa
V
+$555M
2
LLY icon
Eli Lilly
LLY
+$536M
3
META icon
Meta Platforms (Facebook)
META
+$433M
4
PGR icon
Progressive
PGR
+$330M
5
LRCX icon
Lam Research
LRCX
+$294M

Sector Composition

Rank Sector Weight
1 Technology 25.86%
2 Healthcare 15.38%
3 Financials 14.3%
4 Consumer Discretionary 11.43%
5 Industrials 10.56%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DXJ icon
1301
WisdomTree Japan Hedged Equity Fund
DXJ
$7.07B
$1.4M ﹤0.01%
12,700
-11,700
-48% -$1.29M
AOS icon
1302
A.O. Smith
AOS
$8.55B
$1.4M ﹤0.01%
21,400
-18,600
-47% -$1.26M
SWBI icon
1303
Smith & Wesson
SWBI
$649M
$1.39M ﹤0.01%
+149,600
New +$1.54M
AMAL icon
1304
Amalgamated Financial
AMAL
$1.47B
$1.39M ﹤0.01%
48,300
-3,000
-6% -$98.1K
MUR icon
1305
Murphy Oil
MUR
$5.55B
$1.39M ﹤0.01%
48,800
-142,900
-75% -$4.03M
CSTL icon
1306
Castle Biosciences
CSTL
$742M
$1.39M ﹤0.01%
69,200
+57,700
+502% +$1.43M
MERC icon
1307
Mercer International
MERC
$40.5M
$1.38M ﹤0.01%
225,041
+61,100
+37% +$410K
SFD
1308
Smithfield Foods
SFD
$10.8B
$1.38M ﹤0.01%
+67,800
New +$1.39M
CLDT
1309
Chatham Lodging
CLDT
$632M
$1.38M ﹤0.01%
193,853
+42,700
+28% +$354K
COLL icon
1310
Collegium Pharmaceutical
COLL
$1.18B
$1.38M ﹤0.01%
46,300
-25,700
-36% -$785K
ZLAB icon
1311
Zai Lab
ZLAB
$2.07B
$1.38M ﹤0.01%
38,200
+20,000
+110% +$615K
SF
1312
Stifel
SF
$12.4B
$1.38M ﹤0.01%
21,957
-8,250
-27% -$582K
CVEO icon
1313
Civeo
CVEO
$356M
$1.38M ﹤0.01%
59,966
-11,100
-16% -$259K
SRCE icon
1314
1st Source
SRCE
$2.17B
$1.38M ﹤0.01%
23,050
+6,500
+39% +$401K
TDAY
1315
USA Today Co
TDAY
$1.29B
$1.38M ﹤0.01%
476,356
-30,600
-6% -$128K
CRBU icon
1316
Caribou Biosciences
CRBU
$146M
$1.38M ﹤0.01%
1,507,200
+36,500
+2% +$47.4K
NBBK icon
1317
NB Bancorp
NBBK
$993M
$1.37M ﹤0.01%
75,900
+38,500
+103% +$716K
MATW icon
1318
Matthews International
MATW
$887M
$1.37M ﹤0.01%
61,600
-78,700
-56% -$2.05M
TRMD icon
1319
TORM
TRMD
$3.05B
$1.37M ﹤0.01%
83,100
-757,900
-90% -$14.7M
XRN
1320
Chiron Real Estate Inc
XRN
$535M
$1.37M ﹤0.01%
31,280
-2,180
-7% -$90.1K
CUZ icon
1321
Cousins Properties
CUZ
$5.31B
$1.36M ﹤0.01%
46,202
-198,877
-81% -$5.95M
FLNA
1322
Filana Therapeutics
FLNA
$42M
$1.36M ﹤0.01%
908,600
+301,900
+50% +$762K
VTLE
1323
DELISTED
Vital Energy
VTLE
$1.36M ﹤0.01%
64,163
-126,900
-66% -$3.68M
MGNX icon
1324
MacroGenics
MGNX
$233M
$1.36M ﹤0.01%
1,068,200
-50,400
-5% -$132K
DOW icon
1325
Dow Inc
DOW
$22B
$1.35M ﹤0.01%
+38,800
New +$1.49M

Similar funds

Two Sigma Advisers's Q1 2025 Portfolio in Review

As of Q1 2025, Two Sigma Advisers held 2,641 positions worth $44.4B, up 2.8% from $43.2B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Two Sigma Advisers deployed $3.32B of net new capital in Q1 2025, opening 312 new positions and adding to 1,037 existing holdings. Its largest new stake was Regeneron Pharmaceuticals: 553,800 shares worth $351M.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 25% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Visa, an estimated $555M trimmed.

  • Two Sigma Advisers's largest Q1 2025 buy was Regeneron Pharmaceuticals: 553,800 shares worth $351M.
  • Two Sigma Advisers added most to Broadcom in Q1 2025, an estimated $519M increase.
  • Two Sigma Advisers's biggest Q1 2025 reduction was Visa, cutting an estimated $555M.
  • Two Sigma Advisers fully exited Abbott in Q1 2025, selling an estimated $158M.
  • Two Sigma Advisers's ten largest holdings make up 18% of its $44.4B portfolio in Q1 2025.
  • Two Sigma Advisers opened 312 new positions and closed 281 in Q1 2025.
  • Two Sigma Advisers's portfolio value rose 2.8% quarter-over-quarter to $44.4B.

Based on Two Sigma Advisers's 13F filing for Q1 2025, filed 15 May 2025.